| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $7.6M | — | -30.1% |
| SG&A Expense | $4.4M | — | +20.7% |
| Operating Income | -$12.0M | — | +17.3% |
| Interest Expense | $674K | — | +1772.2% |
| Net Income | -$12.3M | — | +12.6% |
| EPS (Basic) | -$8.94 | — | -2693.7% |
| EPS (Diluted) | -$8.94 | — | -2693.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $54.1M | +10.6% | +111.1% |
| Current Assets | $55.0M | +5.6% | +80.0% |
| Total Assets | $56.2M | +5.9% | +77.5% |
| Current Liabilities | $11.8M | +16.8% | -24.8% |
| Long-term Debt | $20.4M | — | +1355.7% |
| Total Liabilities | $21.5M | +104.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.7M | — | +31.4% |
| Capital Expenditures | $10K | — | — |
| Investing Cash Flow | -$10K | — | — |
| Financing Cash Flow | $13.9M | — | +3485.9% |
| Free Cash Flow | -$8.7M | — | +31.3% |
| +31.8% |
| Stockholders' Equity | $34.6M | -18.5% | +126.1% |